Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Aclarubicin
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Aclarubicin
Tree Number(s)
D02.455.426.559.847.562.050.050
D04.615.562.050.050
D09.408.051.059.050
Unique ID
D015250
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015250
Scope Note
An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.
Entry Term(s)
Aclacin
Aclacinomycin A
Aclaplastin
MA-144A1
NSC-208734
Pharm Action
Antibiotics, Antineoplastic
Topoisomerase II Inhibitors
Registry Numbers
74KXF8I502
0
Related Numbers
57576-44-0
CAS Type 1 Name
1-Naphthacenecarboxylic acid,(2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, methyl ester, (1R-(1alpha,2beta,4beta))-
Previous Indexing
Antibiotics, Antineoplastic (1967-1988)
Naphthacenes (1966-1988)
Public MeSH Note
89
History Note
89
Date Established
1989/01/01
Date of Entry
1988/05/16
Revision Date
2016/07/01
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
agonists (AG)
analogs & derivatives (AA)
analysis (AN)
antagonists & inhibitors (AI)
biosynthesis (BI)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Organic Chemicals [D02]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Polycyclic Aromatic Hydrocarbons [D02.455.426.559.847]
Naphthacenes [D02.455.426.559.847.562]
Anthracyclines [D02.455.426.559.847.562.050]
Aclarubicin [D02.455.426.559.847.562.050.050]
Daunorubicin [D02.455.426.559.847.562.050.200]
Plicamycin [D02.455.426.559.847.562.050.650]
Pradimicins and Benanomicins [D02.455.426.559.847.562.050.825]
Polycyclic Compounds [D04]
Polycyclic Aromatic Hydrocarbons [D04.615]
Naphthacenes [D04.615.562]
Anthracyclines [D04.615.562.050]
Aclarubicin [D04.615.562.050.050]
Daunorubicin [D04.615.562.050.200]
Plicamycin [D04.615.562.050.650]
Pradimicins and Benanomicins [D04.615.562.050.825]
Carbohydrates [D09]
Glycosides [D09.408]
Aminoglycosides [D09.408.051]
Anthracyclines [D09.408.051.059]
Aclarubicin [D09.408.051.059.050]
Daunorubicin [D09.408.051.059.200]
Plicamycin [D09.408.051.059.650]
Pradimicins and Benanomicins [D09.408.051.059.825]
Expand All
Collapse All
Aclarubicin
Preferred
Concept UI
M0023487
Registry Numbers
74KXF8I502
Related Numbers
57576-44-0
Scope Note
An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.
Terms
Aclarubicin
Preferred Term
Term UI
T044736
Date
01/01/1999
LexicalTag
NON
ThesaurusID
Aclacinomycin A
Term UI
T044735
Date
05/16/1988
LexicalTag
NON
ThesaurusID
NSC-208734
Narrower
Concept UI
M0350661
Registry Numbers
0
Terms
NSC-208734
Preferred Term
Term UI
T044738
Date
05/16/1988
LexicalTag
LAB
ThesaurusID
UNK (19XX)
MA-144A1
Narrower
Concept UI
M0350662
Registry Numbers
0
Terms
MA-144A1
Preferred Term
Term UI
T044737
Date
05/16/1988
LexicalTag
LAB
ThesaurusID
UNK (19XX)
Aclacin
Narrower
Concept UI
M0431771
Registry Numbers
0
Terms
Aclacin
Preferred Term
Term UI
T505294
Date
07/19/2002
LexicalTag
TRD
ThesaurusID
UK
Aclaplastin
Narrower
Concept UI
M0431772
Registry Numbers
0
Terms
Aclaplastin
Preferred Term
Term UI
T505296
Date
07/19/2002
LexicalTag
TRD
ThesaurusID
DE
page delivered in 0.145s